Liang Xu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Metastatic Breast Cancer

Binding Protein

Top Venues

Research square

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhe Yang, Qi Zhang, Xiaoqing Wu, Siyuan Hao, Xinbao Hao, Elizabeth Jones, Yuxia Zhang, Jianming Qiu, Liang Xu
Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147. Biomedicines 11 (7) (2023)
Lanjing Wei, Qi Zhang, Cuncong Zhong, Lily He, Yuxia Zhang, Ahlam M Armaly, Jeffrey Aubé, Danny R Welch, Liang Xu, Xiaoqing Wu
Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy. Molecular oncology (2023)
Qi Zhang, Zhe Yang, Xinbao Hao, Lauren J Dandreo, Lily He, Yuxia Zhang, Fen Wang, Xiaoqing Wu, Liang Xu
Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling. Cell & bioscience 13 (1) (2023)
Nan Bai, Yusuf Adeshina, Igor Bychkov, Yan Xia, Ragul Gowthaman, Sven A Miller, Abhishek Gupta, David K Johnson, Lan Lan, Erica A Golemis, Peter Makhov, Liang Xu, Manoj M Pillai, Yanis Boumber, John Karanicolas
Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry. Research square (2023)
Nan Bai, Yusuf Adeshina, Igor Bychkov, Yan Xia, Ragul Gowthaman, Sven A Miller, Abhishek Gupta, David K Johnson, Lan Lan, Erica A Golemis, Peter Makhov, Liang Xu, Manoj M Pillai, Yanis Boumber, John Karanicolas
Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry. Research square (2023)
Nan Bai, Yusuf Adeshina, Igor Bychkov, Yan Xia, Ragul Gowthaman, Sven A Miller, Abhishek Gupta, David K Johnson, Lan Lan, Erica A Golemis, Peter Makhov, Liang Xu, Manoj M Pillai, Yanis Boumber, John Karanicolas
Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry. Research square (2023)
Nan He, Sirisha Thippabhotla, Cuncong Zhong, Zachary Greenberg, Liang Xu, Ziyan Pessetto, Andrew K Godwin, Yong Zeng, Mei He
Nano pom-poms prepared exosomes enable highly specific cancer biomarker detection. Communications biology 5 (1) (2022)
Peng Zhang, Xiaoqing Wu, Gulhumay Gardashova, Yang Yang, Yaohua Zhang, Liang Xu, Yong Zeng
Molecular and functional extracellular vesicle analysis using nanopatterned microchips monitors tumor progression and metastasis. Science translational medicine 12 (547) (2021)
Xiaoqing Wu, Gulhumay Gardashova, Lan Lan, Shuang Han, Cuncong Zhong, Rebecca T Marquez, Lanjing Wei, Spencer Wood, Sudeshna Roy, Ragul Gowthaman, John Karanicolas, Philip Gao, Dan A Dixon, Danny R Welch, Ling Li, Min Ji, Jeffrey Aube, Liang Xu
Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis. Communications biology 3 (1) (2020)
Lan Lan, Jiajun Liu, Minli Xing, Amber R Smith, Jinan Wang, Xiaoqing Wu, Carl Appelman, Ke Li, Anuradha Roy, Ragul Gowthaman, John Karanicolas, Amber D Somoza, Clay C C Wang, Yinglong Miao, Roberto De Guzman, Berl R Oakley, Kristi L Neufeld, Liang Xu
Identification and Validation of an Aspergillus nidulans Secondary Metabolite Derivative as an Inhibitor of the Musashi-RNA Interaction. Cancers 12 (8) (2020)
Lan Lan, Minli Xing, Maithri Kashipathy, Justin Douglas, Philip Gao, Kevin Battaile, Robert Hanzlik, Scott Lovell, Liang Xu
Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1. Proteins 88 (4) (2019)
Lan Lan, Hao Liu, Amber R Smith, Carl Appelman, Jia Yu, Sarah Larsen, Rebecca T Marquez, Xiaoqing Wu, Frank Y Liu, Philip Gao, Ragul Gowthaman, John Karanicolas, Roberto N De Guzman, Steven Rogers, Jeffrey Aubé, Kristi L Neufeld, Liang Xu
Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins. BMC cancer 18 (1) (2018)